Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

biomérieux sa - BMXXY

BMXXY

Close Chg Chg %
8.77 -0.75 -8.55%

Open Market

8.02

-0.75 (8.55%)

Volume: 297.00

Last Updated:

Apr 28, 2026, 2:49 PM EDT

Trade Now

Company Overview: biomérieux sa - BMXXY

BMXXY Key Data

Open

$8.02

 Day Range

8.02 - 8.02

52 Week Range

7.98 - 14.62

 Market Cap

$9.64B

Shares Outstanding

1.18B

 Public Float

N/A

Beta

0.86

 Rev. Per Employee

N/A

P/E Ratio

21.48

 EPS

N/A

Yield

70.31%

 Dividend

$0.06

EX-DIVIDEND DATE

Jun 10, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

852.81

  

BMXXY Performance

1 Week
 
 -34.53%
 
1 Month
 
 -33.77%
 
3 Months
 
 -39.33%
 
1 Year
 
 N/A
 
5 Years
 
 N/A
 

BMXXY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Biomérieux Sa - BMXXY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
3.77B 3.97B 4.31B 4.59B
Sales Growth
-5.48% +5.32% +8.36% +6.69%
Cost of Goods Sold (COGS) incl D&A
1.71B 1.79B 1.95B 2.03B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
270.73M 280.44M 327.10M 359.11M
Depreciation
- - 262.20M 288.69M
-
Amortization of Intangibles
- - 64.90M 70.42M
-
COGS Growth
+1.28% +4.79% +8.59% +4.14%
Gross Income
2.06B 2.18B 2.36B 2.57B
Gross Income Growth
-10.44% +5.76% +8.18% +8.80%
Gross Profit Margin
+54.64% +54.87% +54.78% +55.86%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.47B 1.60B 1.72B 1.83B
Research & Development
469.37M 497.42M 531.65M 572.64M
Other SG&A
1.00B 1.10B 1.19B 1.25B
SGA Growth
+3.20% +8.69% +7.39% +6.27%
Other Operating Expense
- - - -
-
Unusual Expense
35.10M 136.11M 20.98M 154.28M
EBIT after Unusual Expense
553.23M 443.04M 618.19M 584.60M
Non Operating Income/Expense
29.32M 7.89M (6.06M) 112.85K
Non-Operating Interest Income
1.26M 1.19M 15.58M 16.14M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.31M 4.76M 17.31M 17.83M
Interest Expense Growth
-59.94% +10.39% +263.83% +3.03%
Gross Interest Expense
4.31M 4.76M 17.31M 17.83M
Interest Capitalized
- - - -
-
Pretax Income
578.25M 446.18M 594.82M 566.88M
Pretax Income Growth
-34.62% -22.84% +33.32% -4.70%
Pretax Margin
+15.33% +11.23% +13.82% +12.34%
Income Tax
115.29M 97.19M 135.00M 118.95M
Income Tax - Current - Domestic
218.60M 211.25M 215.36M 137.69M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(71.36M) (87.46M) (48.46M) 7.67M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
31.95M 26.60M 31.91M 26.41M
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
462.95M 348.98M 459.83M 447.93M
Minority Interest Expense
(12.40M) (37.62M) (7.68M) (677.15K)
Net Income
475.36M 386.61M 467.51M 448.61M
Net Income Growth
-33.09% -18.67% +20.93% -4.04%
Net Margin Growth
+12.60% +9.73% +10.86% +9.77%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
475.36M 386.61M 467.51M 448.61M
Preferred Dividends
- - - -
-
Net Income Available to Common
475.46M 386.61M 467.51M 448.61M
EPS (Basic)
0.4031 0.3272 0.3965 0.3802
EPS (Basic) Growth
-32.91% -18.83% +21.18% -4.11%
Basic Shares Outstanding
1.18B 1.18B 1.18B 1.18B
EPS (Diluted)
0.4014 0.3254 0.3936 0.3775
EPS (Diluted) Growth
-32.83% -18.93% +20.96% -4.09%
Diluted Shares Outstanding
1.18B 1.19B 1.19B 1.19B
EBITDA
859.07M 859.60M 966.27M 1.10B
EBITDA Growth
-26.06% +0.06% +12.41% +13.63%
EBITDA Margin
+22.77% +21.64% +22.45% +23.91%

BioméRieux Sa in the News